A detailed history of Arizona State Retirement System transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 357,193 shares of GILD stock, worth $33.6 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
357,193
Previous 361,503 1.19%
Holding current value
$33.6 Million
Previous $24.8 Million 20.71%
% of portfolio
0.19%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$66.59 - $83.99 $287,002 - $361,996
-4,310 Reduced 1.19%
357,193 $29.9 Million
Q2 2024

Aug 05, 2024

BUY
$63.15 - $72.88 $248,242 - $286,491
3,931 Added 1.1%
361,503 $24.8 Million
Q1 2024

May 07, 2024

BUY
$71.58 - $87.29 $501,990 - $612,164
7,013 Added 2.0%
357,572 $26.2 Million
Q4 2023

Jan 24, 2024

SELL
$73.27 - $83.09 $183,687 - $208,306
-2,507 Reduced 0.71%
350,559 $28.4 Million
Q3 2023

Nov 06, 2023

SELL
$73.94 - $80.67 $288,587 - $314,855
-3,903 Reduced 1.09%
353,066 $26.5 Million
Q2 2023

Aug 01, 2023

BUY
$76.01 - $86.7 $1.1 Million - $1.26 Million
14,507 Added 4.24%
356,969 $27.5 Million
Q1 2023

Apr 27, 2023

BUY
$77.31 - $88.08 $73,831 - $84,116
955 Added 0.28%
342,462 $28.4 Million
Q4 2022

Feb 07, 2023

BUY
$62.32 - $89.47 $34,400 - $49,387
552 Added 0.16%
341,507 $29.3 Million
Q3 2022

Nov 07, 2022

SELL
$59.54 - $68.01 $181,239 - $207,022
-3,044 Reduced 0.88%
340,955 $21 Million
Q2 2022

Jul 28, 2022

SELL
$57.72 - $65.01 $11,717 - $13,197
-203 Reduced 0.06%
343,999 $21.3 Million
Q1 2022

May 04, 2022

BUY
$57.92 - $72.58 $46,799 - $58,644
808 Added 0.24%
344,202 $20.5 Million
Q4 2021

Feb 04, 2022

SELL
$64.88 - $73.64 $411,923 - $467,540
-6,349 Reduced 1.82%
343,394 $24.9 Million
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $157,243 - $169,648
-2,323 Reduced 0.66%
349,743 $24.4 Million
Q2 2021

Aug 02, 2021

SELL
$63.47 - $69.35 $75,085 - $82,041
-1,183 Reduced 0.33%
352,066 $24.2 Million
Q1 2021

May 06, 2021

SELL
$60.0 - $68.46 $509,280 - $581,088
-8,488 Reduced 2.35%
353,249 $22.8 Million
Q4 2020

Jan 28, 2021

SELL
$56.65 - $64.55 $1.12 Million - $1.27 Million
-19,745 Reduced 5.18%
361,737 $21.1 Million
Q3 2020

Nov 05, 2020

BUY
$62.1 - $78.08 $5.26 Million - $6.61 Million
84,645 Added 28.52%
381,482 $24.1 Million
Q2 2020

Aug 04, 2020

BUY
$72.34 - $84.0 $3.6 Million - $4.18 Million
49,742 Added 20.13%
296,837 $22.8 Million
Q1 2020

May 05, 2020

SELL
$62.63 - $80.22 $1.56 Million - $1.99 Million
-24,842 Reduced 9.14%
247,095 $18.5 Million
Q4 2019

Jan 27, 2020

BUY
$61.62 - $67.78 $41,038 - $45,141
666 Added 0.25%
271,937 $17.7 Million
Q3 2019

Oct 31, 2019

SELL
$62.51 - $69.0 $462,323 - $510,324
-7,396 Reduced 2.65%
271,271 $17.2 Million
Q2 2019

Jul 25, 2019

BUY
$61.87 - $69.38 $2.09 Million - $2.34 Million
33,746 Added 13.78%
278,667 $18.8 Million
Q1 2019

Apr 29, 2019

SELL
$62.53 - $70.05 $1.31 Million - $1.46 Million
-20,873 Reduced 7.85%
244,921 $15.9 Million
Q4 2018

Jan 28, 2019

SELL
$60.54 - $79.0 $3.36 Million - $4.39 Million
-55,510 Reduced 17.28%
265,794 $16.6 Million
Q3 2018

Oct 29, 2018

BUY
$71.28 - $78.92 $136,857 - $151,526
1,920 Added 0.6%
321,304 $24.8 Million
Q2 2018

Aug 07, 2018

SELL
$64.88 - $75.68 $361,900 - $422,143
-5,578 Reduced 1.72%
319,384 $22.6 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $437,040 - $532,800
-6,000 Reduced 1.81%
324,962 $24.5 Million
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $515,552 - $605,185
7,246 Added 2.24%
330,962 $23.7 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $23.3 Million - $27.7 Million
323,716
323,716 $26.2 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.